At a glance
ClinicalIndex Comparison RecordN/ACompleted· 122 enrolled
Drug / intervention
Mosaic model 305, model 310, and ultra model 305device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Medtronic Hancock II® and Mosaic Mitral and Aortic Valves: A Study to Observe the Effects of the Stent Material Change to PEEK Post Approval Study (HAMMOCK PAS)
In Brief
An observational study evaluating Mosaic model 305, model 310, and ultra model 305 for Heart Valve Diseases. Completed, enrolled 122 participants across 7 sites in 3 countries.
Detailed Summary
This study is being conducted to satisfy the post-CE approval requirement.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHeart Valve Diseases
CountriesGermany, Poland, United States
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
First PostedMay 2017
Enrollment StartJun 2017
Primary CompletionMay 2019
Study CompletionJun 2021
TodayJul 2026
First PostedMay 4, 2017
Enrollment StartJun 19, 2017
Primary CompletionMay 17, 2019
Study CompletionJun 21, 2021
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 9.2 years ago
Interventions
Mosaic model 305, model 310, and ultra model 305device
Aortic or mitral valve replacement